The role of phosphorus in the development and progression of vascular calcification

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Vascular calcification is a major cause of cardiovascular disease in chronic kidney disease (CKD) patients.
• Hyperphosphatemia, common in CKD, is a key factor promoting vascular calcification.
• Understanding the mechanisms of vascular calcification in CKD is crucial for developing effective treatments.

Purpose of the Study:

• To review the mechanisms by which hyperphosphatemia contributes to vascular calcification in CKD.
• To explore the roles of vascular smooth muscle cells (VSMCs), apoptosis, and specific molecular pathways in this process.
• To discuss the potential for phosphate homeostasis strategies in preventing or reversing vascular calcification.

Main Methods:

• Literature review of studies on vascular calcification in CKD.
• Analysis of the molecular and cellular mechanisms involved in hyperphosphatemia-induced calcification.
• Discussion of the interplay between promoters, inhibitors, and phosphorus handling.

Main Results:

• Hyperphosphatemia promotes VSMC transition to an osteochondrogenic phenotype and matrix mineralization via phosphate cotransporters.
• It induces VSMC apoptosis and inhibits osteoclast-like cell differentiation.
• Elevated FGF23 and decreased klotho expression are associated with vascular calcification in CKD.

Conclusions:

• Hyperphosphatemia plays a central role in the pathogenesis of vascular calcification in CKD through diverse mechanisms.
• The potential for therapeutic interventions targeting phosphate homeostasis requires further investigation.
• A comprehensive understanding of these pathways is essential for managing cardiovascular risk in CKD.